Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome

Table 2 Demographic, clinical and biochemical characteristics of patients with significant liver fibrosis (n = 7)

	PCOS duration (yr)	HOMA-IR	BMI (Kg/m2)	ALT (IU/L)	Triglycerides (mmol/L)	FAI	CAP (dB/m)
Patient 1	10	3.2	31.8	62	0.93	3.1	317
Patient 2	4	1.4	26.2	12	0.91	3.0	186
Patient 3	6	10.9	30.1	88	1.36	5.9	372
Patient 4	13	2.8	28.2	20	0.91	6.3	298
Patient 5	6	5.9	31.2	78	1.66	8.0	346
Patient 6	8	7.9	36.4	101	1.37	3.1	386
Patient 7	13	5.6	20.2	31	2.4	13.9	325

ALT: Alanine aminotransferase; BMI: Body mass index; dB/m: Decibels per meter; CAP: Controlled association parameter; FAI: Free androgen index; HOMA-IR: Homeostasis model for assessment of insulin resistance; PCOS: Polycystic ovary syndrome.